Editors' picks of pharmaceutical science & technology innovations - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Editors' picks of pharmaceutical science & technology innovations
The latest in automation/IT/process control

Pharmaceutical Technology
Volume 37, Issue 7, pp. 18

Process modeling and manufacturing software features a Web-based user interface

The aspenONE software from Aspen Technology incorporates Aspen Plus, Aspen HYSYS, and any data historian into a Web interface that allows users to work with the software through Web-enabled devices. The interface gives users easy access to models and real-time plant information. The software can be used to compare model predictions and actual plant data and to conduct what-if scenarios for troubleshooting or optimizing. The software features a simple user interface and does not require specialized training. The software's search engine is designed for the process industries and enables users to find specific process information from across an enterprise in seconds.

Aspen Technology

Scientific innovation lifecycle management software manages large datasets

Accelrys Enterprise Platform 9.0 is an open, scientifically aware platform capable of managing "big data" and externalized research-collaboration networks. The platform offers enhancements in security, administration, and scientific services, which give organizations new tools for streamlining the lab-to-commercialization value chain and driving innovation in new product development. New capabilities allow for flexible administration and Internet deployments of clients outside of an organization's firewall with enhanced security, which enables secure and efficient interaction with external partners. The platform also offers broad scientific collections that are capable of handling structured and unstructured data, biological sequences, chemical structures, images, and text. The platform's reporting capabilities enable end-users to interpret and interact with data to drive more informed decision-making.



blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here